David A. Stempel

3.2k total citations
103 papers, 2.2k citations indexed

About

David A. Stempel is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, David A. Stempel has authored 103 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Physiology, 79 papers in Pulmonary and Respiratory Medicine and 13 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in David A. Stempel's work include Asthma and respiratory diseases (97 papers), Respiratory and Cough-Related Research (55 papers) and Inhalation and Respiratory Drug Delivery (40 papers). David A. Stempel is often cited by papers focused on Asthma and respiratory diseases (97 papers), Respiratory and Cough-Related Research (55 papers) and Inhalation and Respiratory Drug Delivery (40 papers). David A. Stempel collaborates with scholars based in United States, United Kingdom and Australia. David A. Stempel's co-authors include Richard H. Stanford, Jacqueline R. Carranza Rosenzweig, Stuart Stoloff, Jay Meyer, Anne L. Fuhlbrigge, Stanley J. Szefler, Trent McLaughlin, Craig S. Roberts, Antonio P. Legorreta and Deborah Lucas and has published in prestigious journals such as New England Journal of Medicine, PEDIATRICS and CHEST Journal.

In The Last Decade

David A. Stempel

98 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David A. Stempel United States	28	1.9k	1.6k	280	242	217	103	2.2k
Elisabeth Ståhl Sweden	18	1.1k 0.6×	1.3k 0.8×	72 0.3×	222 0.9×	143 0.7×	28	1.8k
Enric Duran‐Tauleria Spain	24	1.4k 0.7×	1.8k 1.1×	84 0.3×	231 1.0×	135 0.6×	32	2.5k
Karin Lisspers Sweden	27	1.3k 0.7×	1.9k 1.2×	74 0.3×	223 0.9×	72 0.3×	130	2.3k
Graham Douglas United Kingdom	4	1.0k 0.6×	963 0.6×	99 0.4×	101 0.4×	114 0.5×	6	1.3k
J A Friend United Kingdom	20	699 0.4×	774 0.5×	81 0.3×	263 1.1×	54 0.2×	40	1.5k
Mathew Williams New Zealand	17	1.2k 0.7×	1.4k 0.9×	67 0.2×	54 0.2×	89 0.4×	35	1.7k
Brigit VanGraafeiland United States	9	709 0.4×	554 0.4×	102 0.4×	185 0.8×	99 0.5×	21	1.1k
C. Pribil France	22	898 0.5×	606 0.4×	42 0.1×	102 0.4×	539 2.5×	57	1.5k
Miguel Román-Rodríguez Spain	23	1.1k 0.6×	1.4k 0.9×	53 0.2×	112 0.5×	32 0.1×	65	1.6k
Sven‐Arne Jansson Sweden	20	662 0.4×	1.1k 0.7×	36 0.1×	201 0.8×	180 0.8×	36	1.5k

Countries citing papers authored by David A. Stempel

Since Specialization

Citations

This map shows the geographic impact of David A. Stempel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Stempel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Stempel more than expected).

Fields of papers citing papers by David A. Stempel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Stempel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Stempel. The network helps show where David A. Stempel may publish in the future.

Co-authorship network of co-authors of David A. Stempel

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Stempel. A scholar is included among the top collaborators of David A. Stempel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Stempel. David A. Stempel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stempel, David A. & Stanley J. Szefler. (2023). Is the assessment of asthma treatment efficacy sufficiently comprehensive?. Journal of Allergy and Clinical Immunology. 153(3). 629–636. 3 indexed citations

Busse, William W., David A. Stempel, Bhumika Aggarwal, et al.. (2022). Insights from the AUSTRI study on reliever use before and after asthma exacerbations. The Journal of Allergy and Clinical Immunology In Practice. 10(7). 1916–1918.e2. 7 indexed citations

Stempel, David A., Ibrahim Raphiou, Kenneth M. Kral, et al.. (2016). Austri, a Large Randomized Study in Adolescents and Adults with Asthma, Assessing the Safety and Efficacy of Salmeterol in Combination with Fluticasone Propionate Compared to Fluticasone Propionate Alone. Journal of Allergy and Clinical Immunology. 137(2). AB389–AB389. 2 indexed citations

Stempel, David A., Stanley J. Szefler, Søren Pedersen, et al.. (2016). Safety of Adding Salmeterol to Fluticasone Propionate in Children with Asthma. New England Journal of Medicine. 375(9). 840–849. 77 indexed citations

DiSantostefano, Rachael L., Anne Yeakey, Ibrahim Raphiou, & David A. Stempel. (2013). An evaluation of asthma medication utilization for risk evaluation and mitigation strategies (REMS) in the United States: 2005–2011. Journal of Asthma. 50(7). 776–782. 13 indexed citations

Prazma, Charlene M., et al.. (2010). Controller medications and their effects on asthma exacerbations temporally associated with upper respiratory infections. Respiratory Medicine. 104(6). 780–787. 13 indexed citations

Hagiwara, May, Thomas E. Delea, Richard H. Stanford, & David A. Stempel. (2010). Stepping down to fluticasone propionate or a lower dose of fluticasone propionate/salmeterol combination in asthma patients recently initiating combination therapy. Allergy and Asthma Proceedings. 31(3). 203–210. 11 indexed citations

Delea, Thomas E., Richard H. Stanford, May Hagiwara, & David A. Stempel. (2008). Association between adherence with fixed dose combination fluticasone propionate/salmeterol on asthma outcomes and costs. Current Medical Research and Opinion. 24(12). 3435–3442. 54 indexed citations

Stempel, David A., Denise Kruzikas, & Ranjani Manjunath. (2007). Comparative Efficacy and Cost of Asthma Care in Children with Asthma Treated with Fluticasone Propionate and Montelukast. The Journal of Pediatrics. 150(2). 162–167. 17 indexed citations

10.

Stempel, David A., Joseph D. Spahn, Richard H. Stanford, Jacqueline R. Carranza Rosenzweig, & Trent P. McLaughlin. (2006). The economic impact of children dispensed asthma medications without an asthma diagnosis. The Journal of Pediatrics. 148(6). 819–823. 11 indexed citations

11.

Stempel, David A., et al.. (2005). Adherence to asthma controller medication regimens. Respiratory Medicine. 99(10). 1263–1267. 116 indexed citations

12.

O’Connor, Richard D., Jacqueline R. Carranza Rosenzweig, Richard H. Stanford, et al.. (2005). Asthma-related exacerbations, therapy switching, and therapy discontinuation: a comparison of 3 commonly used controller regimens. Annals of Allergy Asthma & Immunology. 95(6). 535–540. 29 indexed citations

13.

Legorreta, Antonio P., Michael S. Blaiss, Eric C. Schneider, et al.. (2004). The utility of the Health Plan Employer Data and Information Set (HEDIS) asthma measure to predict asthma-related outcomes. Annals of Allergy Asthma & Immunology. 93(6). 538–545. 46 indexed citations

14.

Stempel, David A., Lionel Pinto, & Richard H. Stanford. (2002). The risk of hospitalization in patients with asthma switched from an inhaled corticosteroid to a leukotriene receptor antagonist. Journal of Allergy and Clinical Immunology. 110(1). 39–41. 20 indexed citations

15.

Stempel, David A., et al.. (2001). Cost analysis of the use of inhaled corticosteroids in the treatment of asthma: a 1-year follow-up. Respiratory Medicine. 95(12). 992–998. 10 indexed citations

16.

Stempel, David A. & William W. Busse. (1998). Inhaled corticosteroids--first-line preventive therapy in asthma : evidence from the current medical literature. Mosby eBooks. 6 indexed citations

17.

Stempel, David A., et al.. (1996). Drug Utilization Evaluation Identifies Costs Associated with High Use of Beta-Adrenergic Agonists. Annals of Allergy Asthma & Immunology. 76(2). 153–158. 30 indexed citations

18.

Szefler, Stanley J., et al.. (1995). Evolving role of theophylline for treatment of chronic childhood asthma. The Journal of Pediatrics. 127(2). 176–185. 15 indexed citations

19.

Stempel, David A. & Stanley J. Szefler. (1992). Management of Chronic Asthma. Pediatric Clinics of North America. 39(6). 1293–1310. 16 indexed citations

20.

Stempel, David A. & Gregory J. Redding. (1992). Management of Acute Asthma. Pediatric Clinics of North America. 39(6). 1311–1325. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact